Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
The qualifying comorbidities deserve attention because many people have them without realizing it
Peng Y, Felce SL, Dong D, Penkava F, Mentzer AJ, Yao X, et al
Adems, recuerda que los suplementos no deben reemplazar una dieta equilibrada y un estilo de vida saludable
These results clearly demonstrated the protective effects of BPC 157 in Clopidogrel-induced gastric mucosal damage, and the NO system blockade L-NAME could partially attenuate these protective effects of BPC 157 on gastric mucosa
*Correspondence: Qilai Huang, [email protected] These authors contributed equally to this work This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Molecular Biosciences Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers